JP2002531488A5 - - Google Patents

Download PDF

Info

Publication number
JP2002531488A5
JP2002531488A5 JP2000586306A JP2000586306A JP2002531488A5 JP 2002531488 A5 JP2002531488 A5 JP 2002531488A5 JP 2000586306 A JP2000586306 A JP 2000586306A JP 2000586306 A JP2000586306 A JP 2000586306A JP 2002531488 A5 JP2002531488 A5 JP 2002531488A5
Authority
JP
Japan
Prior art keywords
mecamylamine
nicotine
drug
hour
period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000586306A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002531488A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/028697 external-priority patent/WO2000033812A2/en
Publication of JP2002531488A publication Critical patent/JP2002531488A/ja
Publication of JP2002531488A5 publication Critical patent/JP2002531488A5/ja
Pending legal-status Critical Current

Links

JP2000586306A 1998-12-07 1999-12-07 揮発性液体薬剤を送出するための経皮パッチ Pending JP2002531488A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11128598P 1998-12-07 1998-12-07
US60/111,285 1998-12-07
PCT/US1999/028697 WO2000033812A2 (en) 1998-12-07 1999-12-07 Transdermal patch for delivering volatile liquid drugs

Publications (2)

Publication Number Publication Date
JP2002531488A JP2002531488A (ja) 2002-09-24
JP2002531488A5 true JP2002531488A5 (https=) 2006-12-28

Family

ID=22337613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000586306A Pending JP2002531488A (ja) 1998-12-07 1999-12-07 揮発性液体薬剤を送出するための経皮パッチ

Country Status (9)

Country Link
EP (1) EP1137406B2 (https=)
JP (1) JP2002531488A (https=)
KR (1) KR100885235B1 (https=)
AT (1) ATE264098T1 (https=)
AU (1) AU778992B2 (https=)
CA (1) CA2380391A1 (https=)
DE (1) DE69916492T3 (https=)
NZ (2) NZ512788A (https=)
WO (1) WO2000033812A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
ATE288256T1 (de) 1999-01-14 2005-02-15 Noven Pharma Dermale zusammensetzungen
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
ES2310201T3 (es) 2001-02-13 2009-01-01 Government Of The United States Of America, As Represented By The Secretary Of The Army Vacuna para inmunizacion transcutanea contra la diarrea de los viajeros.
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
CN1516595A (zh) * 2001-03-19 2004-07-28 Iomai公司 用于经皮免疫的贴剂
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
ES2294480T3 (es) * 2003-03-14 2008-04-01 Agi Therapeutics Research Limited Tratamiento de afecciones instestinales con n-2,3,3-tetrametilbiciclo(2.1.1)heptan-2-amina.
US20070224284A1 (en) 2004-03-12 2007-09-27 John Devane Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
EP1682102A2 (en) 2003-09-10 2006-07-26 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
MEP23508A (en) 2003-10-28 2010-06-10 Noven Pharma Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
ITMI20041697A1 (it) * 2004-09-03 2004-12-03 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico in forma di cerotto multistrato
US8343538B2 (en) 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
IL177071A0 (en) 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
EP1774964B1 (en) 2005-10-13 2014-08-06 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
DE102006054733A1 (de) 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
CA2733265A1 (en) * 2008-09-30 2010-04-08 Teikoku Pharma Usa, Inc. Transdermal extended-delivery donepezil compositions and methods for using the same
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
MX2012012069A (es) * 2010-04-30 2012-11-22 Teikoku Pharma Usa Inc Composiciones transdermicas de propinilaminoindan.
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
DE102013013397A1 (de) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen
DE102013020633A1 (de) 2013-12-16 2015-06-18 Epinamics Gmbh Dermale und/oder transdermale pharmazeutische Zusammensetzung enthaltend eine terpenoide Verbindung
DE102020112143B4 (de) 2020-05-05 2022-03-17 Lts Lohmann Therapie-Systeme Ag Nicotin - Corona

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717568A (en) * 1985-08-09 1988-01-05 Alza Corporation Laminar arrangement for increasing delivery of beneficial agent from dispenser
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
CH674618A5 (https=) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB8807504D0 (en) 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
DE3908432A1 (de) * 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
DE69422925T2 (de) 1993-07-09 2000-08-17 Cygnus, Inc. Verfahren und vorrichtung für die transdermale oder transbuccale therapeutische verabreichung von nikotinsubstituten
DE4332094C2 (de) 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
ATE246909T1 (de) * 1994-03-07 2003-08-15 Theratech Inc Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung
IL122484A0 (en) * 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5691365A (en) * 1995-07-18 1997-11-25 University Of Kentucky Research Foundation Nicotinic receptor antagonists in the treatment of neuropharmacological disorders
JPH09301853A (ja) * 1996-05-14 1997-11-25 Nitto Denko Corp 貼付剤および貼付製剤

Similar Documents

Publication Publication Date Title
JP2002531488A5 (https=)
US6974588B1 (en) Transdermal patch for delivering volatile liquid drugs
EP1137406B2 (en) Transdermal patch for delivering volatile liquid drugs
JPS63501075A (ja) ベラパミルの経皮供給用デバイス
US5662925A (en) Transdermal delivery system with adhesive overlay and peel seal disc
US5603947A (en) Method and device for providing nicotine replacement therapy transdermally/transbuccally
CA2098196C (en) Method and systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers
KR100893158B1 (ko) 경피성 그라니세트론
CN100457107C (zh) 含有海洛因作为活性物质的药物制剂及其于治疗鸦片成瘾上的用途
WO2000033812A9 (en) Transdermal patch for delivering volatile liquid drugs
Cleary Transdermal delivery systems: a medical rationale
WO2001026705A2 (en) A dual adhesive transdermal drug delivery system
JP2010500992A (ja) アルツハイマー病の経皮的治療法及び経皮的治療システム
JPS6214526B2 (https=)
US20050129749A1 (en) Multi-layer transdermal drug delivery device
JPH08502727A (ja) プリントされた経皮薬剤送達デバイス
WO2009119673A1 (ja) 経皮吸収製剤
CN100571689C (zh) 具有改良的长期附着舒适性的透皮治疗体系
JP2016502989A5 (https=)
JPS6049601B2 (ja) 治療デバイス
CN101155578B (zh) 组合药物
US20100158990A1 (en) Transdermal method and patch for corticosteroid administration
TW418100B (en) Device for transdermal and phonophoretic combination treatment and its therapeutic uses
EP1449527A2 (en) Transdermal patch for administering a volatile liquid drug
JPH0525038A (ja) 経皮吸収製剤